NOOR HUSAIN: Open Payments
NPI 1487836821 · ROSELLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$682 in 27 payments from 12 companies in 2025. Trend: 2023 $274 · 2024 $387 · 2025 $682
Food & beverage: $582Education: $100
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $188 |
| Teva Pharmaceuticals USA, Inc. | 1 | $100 |
| HARMONY BIOSCIENCES LLC | 3 | $75 |
| Lundbeck LLC | 3 | $68 |
| Alkermes, Inc. | 3 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| ABBVIE INC. | 2 | $37 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
Products named: REXULTI, ABILIFY ASIMTUFII, WAKIX, ARISTADA, CAPLYTA, VRAYLAR, INGREZZA, INVEGA SUSTENNA.
Industry payments across IL — which companies pay providers there.
